Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma (COMMAND)

This study has been terminated.
(Interim analysis-DSMB stated good safety profile but lack of efficacy)
Information provided by (Responsible Party):
Verastem, Inc. Identifier:
First received: May 29, 2013
Last updated: October 5, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)